Philogen S.p.A. adotta un processo di gestione delle segnalazioni di illeciti riguardanti la Società in linea con le previsioni normative introdotte dal D.lgs. 10 marzo 2023, n. 24 (c.d. “Decreto Whistleblowing”)....Read more
Following the announcements of this morning, Philogen management is inviting you to a Webinar on December 5 at 15:00 GMT | 16:00 CET.
Please contact us at firstname.lastname@example.org or follow the link below to register to the event:
Philogen to attend the Annual Meeting Cancéropôle Grand Sud-Ouest in Arcachon on November 22-24, 2023.
Prof. Dario Neri, PhD, (CEO and CSO of Philogen) is giving a presentation entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”.
Follow the link here for more details
Philogen is inviting you to a Webinar on October 18 at 14:00 GMT | 15:00 CET following the exciting announcement on our Phase III trial of Nidlegy™ in locally advanced melanoma
The Webinar will be hosted by Prof. Dr. Dario Neri (CEO and CSO), Dr. Laura Baldi (CFO), Dr. Emanuele Puca (Investor Relations). Please follow the link below to register to the Webinar:...Read more
Philogen kindly invites you to attend a virtual briefing for analysts on 2 October 2023 to discuss Company’s Half Year 2023 Results
We are delighted to invite you to our virtual briefing on 2 October 2023 to discuss the Company’s Half Year 2023 Results.Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief...Read more